Our data show that CK2 inhibition with CX-4945 restores IKAROS binding to the MTOR promoter, as well as transcriptional repression of MTOR by IKAROS in high-risk B-ALL cases where there is a deletion of one IKZF1 allele. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.